BioHealth Innovation, Inc.

Our ecosystem is innovating in the field of women’s health. Learn more about these contributions at the 9th Annual Women Building Bio Conference on September 25th! #VaBioWBB2024 #Virginiabio #womeninbio #biotechevents #womenshealth https://bit.ly/3StF0ms Virginia Bio

🎉 Shoutout to BHI EIR, Albine Martin, Ph.D., for her outstanding contributions as a session chair and participant at the recent Next Generation Dx Summit! Dr. Martin's expertise in companion diagnostics played a crucial role in advancing discussions on integrating diagnostics with personalized therapies. Her leadership and insights were instrumental in shaping the conversations on the future of precision medicine. We're proud to have had her represent BioHealth Innovation, Inc. at this important event. https://lnkd.in/e5y9DgQ2

We are pleased to be sponsors of the 10th Annual BioHealth Capital Region Week, which serves as the premier gathering for the biopharma sector, bringing together esteemed government officials, academic leaders, and industry executives. Additionally, partner Derrick Rowe will be in attendance acting as a judge in the 2024 Crab Trap pitch competition, which highlights entrepreneurs with commercially relevant diagnostics, medical devices, therapeutics, and other transformative health solutions. Learn more abut the event, hosted by BioHealth Innovation, Inc., at: https://lnkd.in/gAmTPd8c

The Latest BHI Weekly E-Newsletter is live with stories including: ⏳ Two Weeks Left! Apply for the 9th Annual Crab Trap Competition Before August 30th - Submit your application for the September 18th competition at USP, Rockville, MD. 🌍 Bringing the BioHealth Capital Region to South Africa: BioTalk features insights from Johann de Bruyn, CA(SA), MBA, Ethan Hunter, and Dr. Carla Eksteen. 🗳️ Association of University Research Parks (AURP) partners in support of the 10th Annual BioHealth Capital Region Forum 👩🔬 Women In Bio - Engage. Educate. Empower. (WIB) to Participate in the 10th Annual BioHealth Capital Region Forum 💵 Biden-Harris Administration Announces $150 Million from Advanced Research Projects Agency for Health (ARPA-H) for Cancer Moonshot Goals - New funding to advance cancer research and health outcomes. 📈 TEDCO’s Maryland Innovation Initiative Invests $2.1M - Seven companies receive funding to advance Maryland-based innovations. 🧬 AstraZeneca’s Imfinzi Approved in the US for NSCLC - New approval for treating resectable non-small cell lung cancer before and after surgery. 🏗️ United Therapeutics Corporation to Build Medical Transplant Center in Minnesota - New facility for gene-edited organ research to support clinical trials. 📢 TEDCO Promotes Kim Mozingo to Vice President, Federal Programs to lead federal programs aimed at transforming scientific research into economic growth. https://lnkd.in/eVi6Wfmf

Welldoc is pioneering the use of #AI to revolutionize diabetes management. Our groundbreaking general purpose transformer based CGM research represents a significant leap forward in predicting glucose levels for individuals living with both Type 1 and Type 2 #diabetes. In our clinical presentation at the Machine Learning for Healthcare (#MLHC) annual meeting this past weekend in Toronto, Welldoc shared the first study in a series that demonstrates Welldoc's novel methodology towards predicting future continuous glucose monitoring (#CGM) glucose levels with high accuracy. The poster presents Welldoc's state-of-the-art AI models, which can predict glucose trajectories at 30-, 60- and 120-minute intervals for both type 1 and type 2 diabetes populations with ~ 50% less root mean square error, when compared to existing benchmark studies. Welldoc's #GPT model, “CGM-GPT,” was trained only on CGM data sets from individuals living with Type 1 and Type 2 diabetes, and reflects the advanced opportunity to develop sophisticated large sensor models (LSM) by leveraging the vast data available via real-time sensors. We're committed to further refining our models by incorporating additional data sources and exploring expanded applications. This ongoing research will drive the development of innovative diabetes management solutions. Stay tuned for additional information on our exciting transformer based CGM research! https://lnkd.in/gHw7y9iQ #Welldoc #DigitalHealth

Meet the CRO Services Sponsors of Our Crab Trap Pitch Competition: Noble Life Sciences Inc & Accelevir The 9th Annual Crab Trap Competition offers startups a chance to showcase their innovations for a cash and services prize. (Apply at https://lnkd.in/epimYt5r) Noble Life Sciences and Accelevir are contributing $10,000 in CRO research services to the winner. About the Sponsors: ●      Noble Life Sciences: A full-service preclinical CRO, offering comprehensive preclinical drug development services to help biotech startups navigate the regulatory landscape and accelerate their programs. https://noblelifesci.com/ ●      Accelevir: Ultra-sensitive Detection of Ultra-Rare Targets in Infectious Diseases, Immuno-Oncology, and Beyond. We develop innovative assays that enable novel therapeutic discoveries, advancing human health and well-being. https://lnkd.in/eha7qVYP Together, these industry leaders are committed to supporting innovation in life sciences from preclinical to clinical phases. Learn more by visiting https://lnkd.in/eFfu6z-G

Did you know that after the Crab Trap at the BioHealth Capital Region Forum last year at USP, someone took the idea back to South Africa and held their own competition with start-ups and students called Bio Centrifuge Africa? 🌍 This really did happen, and the visionary behind Bio Centrifuge Africa, along with the competition winners, joins Richard Bendis on BioTalk! They’re here to discuss how their groundbreaking work connects South Africa’s biotech scene with the BioHealth Capital Region, showcasing the power of international innovation. Johann de Bruyn, CA(SA), MBA, CEO of TASK, introduces Bio Centrifuge Africa and its mission, along with bridging the gap between South Africa’s biotech sector and the established BHCR. Ethan Hunter, COO of Immobazyme, reflects on winning Bio Centrifuge Africa and the thrilling opportunity to compete in the 9th Annual Crab Trap in Maryland this September. Carla Eksteen, PhD, Postdoctoral Research Fellow at Stellenbosch University, shares her insights into cancer immunotherapy and her upcoming trip to Maryland as part of the competition prize. Listen now on your favorite podcast platform: 🍏 Apple: https://apple.co/3SUCMwz 🎧 Spotify: https://spoti.fi/3XbF9wv 🎵 Amazon Music: https://amzn.to/3Mbzph1 📻 TuneIn: https://bit.ly/3MbzqBB This episode offers a fascinating look at how South African innovators are making waves on the global biotech stage and highlights the impact of international collaborations in driving the industry forward. Tune in to BioTalk for an enlightening discussion with Johann de Bruyn, Ethan Hunter, and Dr. Carla Eksteen as they share their experiences and vision, linking South African biotech innovation with the BioHealth Capital Region. Editing and post-production work for this episode was provided by The Podcast Consultant (https://lnkd.in/ex8-nhdQ).

This week, our Director Renee Wegrzyn had the honor of standing alongside President Joe Biden and First Lady Dr. Jill Biden when they announced up to $150 million in ARPA-H awards to eight trailblazing teams selected for our PSI program to create new technology that ensures perfect cancer tumor removal. These performer teams are stepping closer to answering, “what if surgeries fixed problems flawlessly, the first time?” https://lnkd.in/eX3ABF6z During the event in New Orleans where President Biden and the First Lady delivered remarks on the announcement, President Biden said, “When Jill and I reignited the #CancerMoonshot in our administration, we were determined to launch this new outfit called ARPA-H. And that’s what we did… ARPA-H has so far committed more than $400 Million to ending cancer as we know it. A year ago, ARPA-H set its sights on a big idea, calling on researchers and innovators to pioneer new techniques and technologies to make cancer removal more precise, accurate, and successful. Imagine cancer surgery that removes all of the tumor the first time, without harming healthy cells… Today we’re announcing $150 Million ARPA-H funding for some of the nation’s cutting-edge cancer research institutions.”

Excited to participate in the BioHealth Capital Region Forum this September, on the panel moderated by Amy Adams! Honored to share the stage with Kolaleh Eskandanian, PhD, MBA, PMP of Children's National Hospital and Robert Storey Medtech Exec and Managing Partner of The LaunchPort™. Join us as we discuss the latest in Medtech innovations shaping our Region's biohealth industry. Click here to learn more about the event and register! https://lnkd.in/enxYKgyv #innovation #medicaldevices #ContractManufacturing BioHealth Innovation, Inc.

This week, our Director Renee Wegrzyn had the honor of standing alongside President Joe Biden and First Lady Dr. Jill Biden when they announced up to $150 million in ARPA-H awards to eight trailblazing teams selected for our PSI program to create new technology that ensures perfect cancer tumor removal. These performer teams are stepping closer to answering, “what if surgeries fixed problems flawlessly, the first time?” https://lnkd.in/eX3ABF6z During the event in New Orleans where President Biden and the First Lady delivered remarks on the announcement, President Biden said, “When Jill and I reignited the #CancerMoonshot in our administration, we were determined to launch this new outfit called ARPA-H. And that’s what we did… ARPA-H has so far committed more than $400 Million to ending cancer as we know it. A year ago, ARPA-H set its sights on a big idea, calling on researchers and innovators to pioneer new techniques and technologies to make cancer removal more precise, accurate, and successful. Imagine cancer surgery that removes all of the tumor the first time, without harming healthy cells… Today we’re announcing $150 Million ARPA-H funding for some of the nation’s cutting-edge cancer research institutions.”